Y Intercept (Hong Kong) LTD Corcept Therapeutics Inc Transaction History

Y Intercept (Hong Kong) LTD

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$21.97 - $33.8 $170,597 - $262,457	7,765 New	7,765 $211,000
Q4 2022 Feb 14, 2023	BUY	$19.95 - $29.96 $222,223 - $333,724	11,139 New	11,139 $226,000
Q2 2022 Aug 08, 2022	SELL	$17.33 - $25.3 $204,182 - $298,084	-11,782 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$16.53 - $25.21 $194,756 - $297,024	11,782 New	11,782 $265,000

350

86.1M

1.12M

667K

Ticker CORT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,105,000
Market Cap $5.92B
Description
Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...

Get notified when there are updates to the investment portfolio of Y Intercept (Hong Kong) LTD, based on Form 13F filings with the SEC.

Stay updated on Y Intercept (Hong Kong) LTD with notifications on news.